Yannick Plétan
Directeur Technique/Scientifique/R&D chez DEINOVE
Provenance du réseau au premier degré de Yannick Plétan
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 20 | |
20
| Private Company | Biotechnology | 20 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
16
| Subsidiary | Pharmaceuticals: Major | 16 |
| Holding Company | Pharmaceuticals: Major | 12 | |
| Public Company | Biotechnology | 7 | |
| Public Company | Medical Specialties | 7 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Yannick Plétan via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ROCHE HOLDING AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal Chairman Director/Board Member Public Communications Contact Director/Board Member Director/Board Member | |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Founder Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| INSEAD | College/University | Masters Business Admin Director/Board Member Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member | |
| University of St. Gallen | College/University | Corporate Officer/Principal Undergraduate Degree Graduate Degree Undergraduate Degree | |
Stiftung Avenir Suisse
 Stiftung Avenir Suisse Investment Trusts/Mutual FundsMiscellaneous Stiftung Avenir Suisse develops ideas for the sociopolitical and economic development of Switzerland. It comprises of companies and private individuals from all economic branches and regions of Switzerland. The company was founded in 1999 and is headquartered in Zurich, Switzerland. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member Director/Board Member | |
| University of Lyon | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
Minka Therapeutics SA
 Minka Therapeutics SA Pharmaceuticals: MajorHealth Technology Minka Therapeutics SA develops therapeutic products and diagnostic complementary to current antiretroviral therapy in the treatment of AIDS. The firm provides therapeutic and diagnostic solutions for diseases linked to the immune system through its research on immune dysregulations. The company was founded by Patrice Debre, Vincent Vieillard, Michel Klein, Joël Crouzet, and Robert L. Murphy in 2008 and is headquartered in Evry, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree | |
| Université de Montpellier | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Doctorate Degree Doctorate Degree Masters Business Admin | |
| ABIVAX | Pharmaceuticals: Other | Founder General Counsel Director/Board Member | |
| Artedrone SAS | Director/Board Member Director/Board Member | ||
| SANOFI | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
UroMems SAS
 UroMems SAS Medical SpecialtiesHealth Technology UroMems SASdesigns and develops implantable medical devices. Its product is an active implantable medical device which compensates for sphincter insufficiency with the help of a MyoElectroMechanical System. The company was founded by Hamid Lamraoui in 2011 and is headquartered in Grenoble, France. | Medical Specialties | Director/Board Member Director/Board Member | |
| LUFTHANSA | Airlines | Chief Executive Officer Corporate Officer/Principal | |
| ECOSLOPS SA | Trucking | Director/Board Member Director/Board Member | |
| TRANSGENE | Biotechnology | Director/Board Member Director/Board Member | |
LimFlow SA
 LimFlow SA Medical SpecialtiesHealth Technology LimFlow SA develops and offers medical devices which transformes the treatment of critical limb Ischemi. The firm?s proprietary and CE marked technology is a novel and purely percutaneous therapy for ?no-option? CLI patients. The company was founded by Martin T. Rothman in 2012 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member Director/Board Member | |
GamaMabs Pharma SA
 GamaMabs Pharma SA Medical/Nursing ServicesHealth Services GamaMabs Pharma SA specializes in developing monoclonal antibodies. It offers research and development solutions for biopharmaceutical industry. The company was founded by Jean-Francois Prost and Stephane Degove in June 2013 and is headquartered in Toulouse, France. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
ADEMTECH SA
 ADEMTECH SA Miscellaneous Commercial ServicesCommercial Services ADEMTECH SA specializes in developing and manufacturing magnetic nanoparticles for diagnostic and scientific research applications. The firm produces magnetic nanoparticles for concentration, separation, purification, microfluidic device integration and identification of molecules and specific cells. The company was founded in 2000 and is headquartered in Pessac, France. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
CorWave SA
 CorWave SA Medical SpecialtiesHealth Technology CorWave SA develops and manufactures blood pumps. The company was founded in 2011 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member Director/Board Member | |
| Sorbonne Université | College/University | Masters Business Admin Graduate Degree | |
| MEDESIS PHARMA S.A. | Biotechnology | Director/Board Member Corporate Secretary | |
| European Round Table of Industrialists | Corporate Officer/Principal Corporate Officer/Principal | ||
Algotherapeutix SAS
 Algotherapeutix SAS Medical SpecialtiesHealth Technology AlgoTherapeutix SAS is a clinical-stage biotechnology company based in Suresnes, France. The French company is focused on developing targeted, first-in-class therapeutics for peripheral neuropathic pain. Its lead asset, ATX01, is a proprietary topical formulation of amitriptyline that targets the signaling pathways involved in the regulation of pain by inhibiting specific nociceptive sodium channel receptors. The company is currently recruiting patients for a phase II clinical trial of 240 patients for chemotherapy-induced neuropathic pain and a phase II proof of concept trial for erythromelalgia. AlgoTherapeutix has secured FDA fast track development status and orphan drug designation in both the US and EU. AlgoTherapeutix has raised EUR 35 million to date and has a consortium of investors, including Relyens Innovation Santé/Turenne Capital, UI Investissement, and angel investors. The company was founded in 2018 by Olivier Jean Bohuon and Stéphane Thiroloix, with Stéphane Thiroloix serving as the CEO since 2018. | Medical Specialties | Chairman Director/Board Member | |
| GIVAUDAN SA | Food: Specialty/Candy | Director/Board Member Director/Board Member | |
| ATON | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
| ADVICENNE | Pharmaceuticals: Generic | Chairman Director/Board Member | |
BPIFrance Investissement SAS
 BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Investor Private Equity Analyst | |
| GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| PHAXIAM THERAPEUTICS S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Keranova SA
 Keranova SA Medical SpecialtiesHealth Technology Keranova SA designs and develops surgical equipment for various ophthalmologic indications that involve the anterior segment of the eye. The company was founded by Fabrizio Romano on September 4, 2015 and is headquartered in Saint-Etienne, France. | Medical Specialties | Director/Board Member Director/Board Member | |
| TXCELL | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| VOLUNTIS S.A. | Packaged Software | Director/Board Member Director/Board Member | |
| University of Oxford | College/University | Corporate Officer/Principal Doctorate Degree | |
| Swiss Federal Institute of Technology | College/University | Undergraduate Degree Doctorate Degree | |
| PHARNEXT SCA | Biotechnology | Founder Director/Board Member | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Founder Director/Board Member | |
Groupe hospitalier Pitié-Salpêtrière
 Groupe hospitalier Pitié-Salpêtrière Hospital/Nursing ManagementHealth Services Groupe hospitalier Pitié-Salpêtrière is a part of the AP-HP, which is the CHU of Ile-de-France and is based in Paris, France. The AP-HP has 38 hospitals that receive 8.3 million patients every year. The French company provides medical, social, and legal support to victims of violence through its Maison des Femmes program. The private company also has several research chairs in different fields and all of its clinical services are subject to regulatory certification by the Haute Autorité de Santé (HAS). The company uses indicators to regularly evaluate the quality and safety of the care it provides. The company also has a team of social workers who can help patients with their needs outside of the hospital. The company has protocols for cooperation between healthcare professionals to extend the scope of activities of paramedics while ensuring the quality and safety of care. | Hospital/Nursing Management | Corporate Officer/Principal Corporate Officer/Principal | |
| NEOVACS | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| CHUGAI PHARMACEUTICAL CO., LTD | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistiques
Internationale
| France | 41 |
| Suisse | 6 |
| Etats-Unis | 2 |
| Allemagne | 2 |
| Belgique | 2 |
Sectorielle
| Health Technology | 26 |
| Consumer Services | 11 |
| Commercial Services | 5 |
| Transportation | 3 |
| Health Services | 3 |
Opérationnelle
| Director/Board Member | 449 |
| Corporate Officer/Principal | 173 |
| Chairman | 113 |
| Chief Executive Officer | 67 |
| Independent Dir/Board Member | 63 |
Relations les plus connectées
| Insiders | |
|---|---|
| André S. Hoffmann | 52 |
| Philippe Pouletty | 51 |
| Alain Munoz | 38 |
| Célia Hart | 36 |
| Charles Woler | 29 |
| Alain Parthoens | 29 |
| Paul Bulcke | 28 |
| Christoph Franz | 27 |
| Carole Nüchterlein | 26 |
| Philippe Archinard | 24 |
| Philippe Boucheron | 24 |
| Eric Nemeth | 23 |
| Severin Schwan | 23 |
| Patrick Frost | 21 |
| Joël Jean-Louis Besse | 20 |
- Bourse
- Insiders
- Yannick Plétan
- Connexions Sociétés
